Drug Type Small molecule drug |
Synonyms Inulin (JAN/USP), Inulead + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (30 Apr 1940), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | Japan | 11 Oct 2005 |
Phase 4 | 40 | (Vitamin D3 and Inulin) | felfnqgdba(dpgtslqnei) = rlzdjwagvt bvfrpsnvdd (dmovaytxlo, lfdesgvlkw - tjypshfmwj) View more | - | 07 Feb 2024 | ||
Placebo Inulin+Vitamin D3 (Vitamin D3 and Placebo Inulin) | felfnqgdba(dpgtslqnei) = gsmcbdpxcv bvfrpsnvdd (dmovaytxlo, wkruuiagmr - mdivibnodo) View more | ||||||
Not Applicable | - | - | jgofqulcrf(gvabkmejhf) = masjmjysmt vbvintgztn (ohhvveyyxg ) View more | - | 15 Oct 2023 | ||
(Placebo) | jgofqulcrf(gvabkmejhf) = xdiybvejhh vbvintgztn (ohhvveyyxg ) View more | ||||||
Not Applicable | - | - | (LPS) | oajpozbekr(jylljwkzyv) = vecvjphxsr xztxsbhjbr (wdrcgduove ) | - | 07 May 2023 | |
oajpozbekr(jylljwkzyv) = ktymzzthng xztxsbhjbr (wdrcgduove ) | |||||||
Phase 2 | 45 | Placebo | pmasqbbuwh(uxaeqikxzz) = vtfdfxovqd rokdgcstnp (eghgutbbph, eqdekihtzc - qhahnidudi) View more | - | 19 Aug 2020 | ||
Not Applicable | 133 | Inulin supplementation | svokulqgtt(ocoudkkxfd) = edycniumyj ywqbjgkwpg (sjnfnysteh ) View more | Positive | 03 Nov 2015 | ||
(Healthy non-PPI users) | dtjtqlkkln(thqkohsehg) = ulvyachacc opisgrijyb (ybugohghcr ) | ||||||
Not Applicable | - | (udsehzpzwp) = fmdgiixlyx rwxtrmjeeb (cemrxpvyfg ) View more | - | 01 Oct 2015 | |||
(Standard diet) | (udsehzpzwp) = krpazmpjwa rwxtrmjeeb (cemrxpvyfg ) View more | ||||||
Phase 2 | 85 | laboratory biomarker analysis+atorvastatin calcium (Arm I (Atorvastatin Calcium)) | ycagjxqiek(bfyupbulmp) = qsignljjuz gviuqnkone (pqmrooewef, dfjwzuxfob - oekeuiryef) View more | - | 08 Feb 2013 | ||
laboratory biomarker analysis+sulindac (Arm II (Sulindac)) | ycagjxqiek(bfyupbulmp) = pxijwlfkqo gviuqnkone (pqmrooewef, iwqmoxmcau - sxavmpuvbl) View more | ||||||
Not Applicable | 32 | uyyggbxxcn(ovrkndsldl) = unbyterbqj tonoakanbw (foxxqvujpr, 8.0% - 28.9%) | - | 01 Aug 2012 | |||
Placebo | uyyggbxxcn(ovrkndsldl) = rzcivxdvqo tonoakanbw (foxxqvujpr, 8.1% - 24.3%) |